Condition: RASopathy · Costello Syndrome · Cardio-Facio-Cutaneous Syndrome · Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
RASopathies are a group of syndromes, caused by variants of genes involved in the regulation of the Ras/MAP/ERK pathway. This intracellular transduction pathway profoundly affects embryogenic development, organogenesis, synaptic plasticity and neuronal growth. RASopathies are characterized by multi-organ involvement, growth delay, premature aging and haemato-oncological manifestations. Based on evidences provided by literature, cancer screening protocols are applied in some individuals affected by RASopathies, even though detailed information about prevalence and molecular pathogenesis of such tumors is still not clearly elucidate.
This description comes directly from the study's public registry record.
Chiara Leoni, MD, PhD · 0039063381344 · chiara.leoni@policlinicogemelli.it
Always discuss trial participation with your own doctor first.
| Department of Woman and Child Health and Public Health, Fondazione Policlinico A. Gemelli, IRCCS | Roma, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05761314